Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Resilience-Focused Acceptance and Commitment Therapy (ReACT) Program: The Resilience-Focused Acceptance and Commitment Therapy (ReACT) program is a structured, group-based psychological intervention specifically designed for women who have undergone mastectomy following breast cancer. The program consists of three weekly 90-minute sessions integrating core ACT processes, including acceptance, defusion, mindfulness, values clarification, and committed action, with an emphasis on building psychological resilience, self-compassion, and enhancing perceived social support. The program uniquely combines evidence-based ACT techniques with group exercises focused on post-cancer psychosocial adjustment.

No intervention: Standard Care

Study summary

The goal of this clinical trial is to investigate the effects of an Acceptance and Commitment Therapy (ACT) based program (ReACT) to increase social support, compassion and psychological flexibility on psychological resilience in women undergoing mastectomy. The main question it aims to answer is: Does the ReACT program improve participants' resilience by increasing social support, compassion, and psychological flexibility? Researchers will compare intervention group to control group to see if ReACT program works to improve participants' resilience.

Researchers will randomly divide participants into two groups: intervention group and control group.

* Participants will complete some questionnaires.
* Participants in the intervention group will join a 3-week ACT-based psychological flexibility program. This program consists of sessions that last 90 minutes each. The program adopts the core principles of ACT and aims to help participants develop skills in mindfulness, acceptance, value-driven living, and cognitive defusion.
* Participants will complete the same questionnaires again after the program.
* Participants will complete the same questionnaires again 1 month after the program ends.

Eligibility

Primary outcome measure(s)

• Resilience — three weeks
  Psychological resilience will be assessed using the Brief Resilience Scale (BRS). The outcome will measure changes from baseline (pre-intervention) to post-intervention (immediately after the 3-week program). The Brief Resilience Scale evaluates the individual's ability to recover from stress and adversity.

Trial sites (1)

More Medipol University trials in Turkey

Other trials for the same condition